GoHealth, Inc.
GOCO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $798,894 | $734,671 | $631,675 | $1,062,415 |
| % Growth | 8.7% | 16.3% | -40.5% | – |
| Cost of Goods Sold | $130,612 | $158,961 | $187,670 | $239,335 |
| Gross Profit | $668,282 | $575,710 | $444,005 | $823,080 |
| % Margin | 83.7% | 78.4% | 70.3% | 77.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $82,116 | $93,069 | $116,530 | $98,183 |
| SG&A Expenses | $317,812 | $298,111 | $324,089 | $463,324 |
| Sales & Mktg Exp. | $235,696 | $205,042 | $207,559 | $365,141 |
| Other Operating Expenses | $357,517 | $359,280 | $438,582 | $849,203 |
| Operating Expenses | $675,329 | $657,391 | $762,671 | $1,312,527 |
| Operating Income | -$7,047 | -$81,681 | -$318,666 | -$489,447 |
| % Margin | -0.9% | -11.1% | -50.4% | -46.1% |
| Other Income/Exp. Net | $1,995 | -$69,435 | -$56,954 | -$44,771 |
| Pre-Tax Income | -$5,052 | -$151,116 | -$375,620 | -$534,218 |
| Tax Expense | $2,267 | $154 | $764 | -$24 |
| Net Income | -$2,928 | -$63,257 | -$148,706 | -$189,357 |
| % Margin | -0.4% | -8.6% | -23.5% | -17.8% |
| EPS | -0.66 | -7.19 | -17.72 | -26.85 |
| % Growth | 90.8% | 59.4% | 34% | – |
| EPS Diluted | -0.66 | -7.19 | -17.72 | -26.85 |
| Weighted Avg Shares Out | 9,980 | 9,292 | 8,445 | 7,066 |
| Weighted Avg Shares Out Dil | 9,980 | 9,292 | 8,445 | 7,066 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $72,868 | $69,472 | $57,069 | $33,505 |
| Depreciation & Amortization | $105,890 | $105,748 | $107,002 | $107,507 |
| EBITDA | $173,706 | $24,104 | -$211,549 | -$393,206 |
| % Margin | 21.7% | 3.3% | -33.5% | -37% |